Annual report highlights progress in science, medicines and health in 2023 31 May 2024 All news https://www.ema.europa.eu/en/news/annual-report-highlights-progress-science-medicines-health-2023
European regulation on medical devices: end of transition period 27 May 2024 All news https://ansm.sante.fr/actualites/reglement-europeen-relatif-aux-dispositifs-medicaux-fin-de-la-periode-de-transition
Certification of medical devices: a second European notified organization for France 21 May 2024 All news https://ansm.sante.fr/actualites/certification-des-dispositifs-medicaux-un-deuxieme-organisme-notifie-europeen-pour-la-france
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 May 2024 17 May 2024 All news https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-13-16-may-2024
Permanent Scientific Committee on Monitoring and Pharmacovigilance – Restricted Expertise Session of 30 January 2024 13 May 2024 All news France-Permanent-Scientific-Committee-for-Pharmaco-Surveillance-_09May2024-ibuprofen-1Download
United Kingdom – Guidance: Send and receive information on adverse drug reactions (ADRs) 6 May 2024 All news https://www.gov.uk/guidance/send-and-receive-information-on-adverse-drug-reactions-adrs
Quick guide – Transitional trials from EudraCT to CTIS (sponsor users) 3 May 2024 All news https://www.ema.europa.eu/en/documents/other/sponsors-guide-transition-trials-eudract-ctis-ctis-training-programme-module-23_en.pdf
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 April 2024 29 April 2024 All news https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-22-25-april-2024
New recommendations to strengthen supply chains of critical medicines 26 April 2024 All news https://www.ema.europa.eu/en/news/new-recommendations-strengthen-supply-chains-critical-medicines
List of medicines under additional monitoring 22 April 2024 All news https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/pharmacovigilance-post-authorisation/medicines-under-additional-monitoring/list-medicines-under-additional-monitoring
